著者
西内 偉格 甲斐 包子 吉田 真里子 高岸 靖 山田 秀雄 永井 修吾 刈谷 巽 佐々木 緊
出版者
The Japanese Society for the Study of Xenobiotics
雑誌
薬物動態 (ISSN:09161139)
巻号頁・発行日
vol.5, no.2, pp.165-177, 1990 (Released:2007-03-29)
参考文献数
14
被引用文献数
5

The absorption, distribution, excretion and metabolism of recombinant human interleukin-2 (S-6820) were studied following intravenous or subcutaneous injection at a dose of 5×105U/kg to rats. Concentrations of S-6820 in serum, tissues and other body fluids were measured by a bioassay and an enzyme immunoassay. 1. After intravenous injection of S-6820 to rats, serum levels of S-6820 decreased biphasically and the half-lives of the α phase and β phase were 2. 4 min and 16min, respectively. 2. Absorption ratio after subcutaneous injection of S-6820 was about 37%.3. After repeated intravenous injection of S-6820 once a day for 5 days, the levels of S-6820 in serum and tissues reached the same levels as after single administration. No accumulation was observed.4. After intravenous injection of S-6820, especially high level was observed in the kidney, however, it decreased rapidly (t1/2=11min). The levels of S-6820 in the other organs (spleen, lung, heart and liver) were lower than the serum level.5. After intravenous injection of S-6820 to 20-th day pregnant rat, S-6820 in the amniotic fluid and fetus was not detected.6. After intravenous injection to lactating rats, the transfer of S-6820 from blood to milk was minimal.7. A little of S-6820 was found in the bile by EIA. S-6820 was not detected in the urine by EIA method.8. The disappearance rates of S-6820 in rats changed from t1/2(β)=0.41hr in sham operated rats to t1/2(β)=1.57hr in rats with renal excision. The kidney appeared to be the main metabolic site.